Pharmacokinetics linearity [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-05-29 11:03 (3551 d 10:07 ago) – Posting: # 14881
Views: 4,362

Dear PJS
I do not know if I get things right, but IMHO the whole discussion would only make sense if you claim bioequivalence of your BE formulation (25mg/5ml sol which will be tested vs 25 mg tab ) also to the lower tablet strength (i.e. 5mg/1ml sol vs 25 mg tab). But as far as I understood you want to waive the 5mg/5ml strength. This is a different formulation (not dose proportional composition) and consequently you will need another BE study.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
39 visitors (0 registered, 39 guests [including 9 identified bots]).
Forum time: 20:11 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5